Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (12)
P 3 (1)
P 4 (2)

Trial Status

Completed7
Not Yet Recruiting5
Recruiting5
Unknown3
Withdrawn1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT07358949Not Yet RecruitingPrimary

Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i

NCT07569913Not ApplicableNot Yet Recruiting

A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test

NCT07563309Not ApplicableRecruiting

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

NCT07525076Not ApplicableNot Yet Recruiting

Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department

NCT07089836Recruiting

This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.

NCT07397403Phase 4RecruitingPrimary

The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.

NCT06716450Not ApplicableRecruiting

Multiplo Tp/HIV Self-Test

NCT05831098Not ApplicableCompletedPrimary

Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT

NCT06463314Not ApplicableWithdrawn

Multiplo Near Patient Non-HCP Study

NCT06391125Phase 3RecruitingPrimary

LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment

NCT05534633Not ApplicableActive Not Recruiting

APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies

NCT06584214Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syphilis Advanced Test.

NCT06367621Completed

Retrospective Study of iStatis Syphilis Ab Test (POC)

NCT06365606Not ApplicableCompletedPrimary

Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis Syphilis Ab Test at the Point- Of-Care Sites

NCT04050540Phase 4Completed

Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP

NCT06244966Not ApplicableNot Yet Recruiting

GUM Remote Testing v4.0

NCT05063344CompletedPrimary

NOWDx Test for the Diagnosis of Syphilis

NCT04455425Completed

Acquired Syphlis by Non Sexual Contact

NCT05727033Not ApplicableUnknown

Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections

NCT05692505Unknown

Multicenter Performance Study of QuadQuik Invitro Diagnostic Device

Scroll to load more

Research Network

Activity Timeline